Genome BC Joins Open Office Experts

Published on Friday, January 30, 2015


Providing insight, support, and advice for genomics and life science startups at e@UBC

After the successful Spotlight Speaker Series held in November 2014 and the recent partnership with the genomics.entrepreneurship@UBC GREAT Program, Genome BC is joining Open Office with a bi-weekly schedule to meet one-on-one with e@UBC registered ventures. Dr. Gabe Kalmar, Vice President Sector Development and Dr. Rachel Ritchie, Director of Business Development offer their years of experience with early-stage genomics and life science ventures to e@UBC. With exclusive knowledge of alternative financing and experience navigating the academic and commercial landscape, both advisors will jump start registered ventures seeking financial, technical, and business opportunities and support in life science and genomics. See their full bios below.

Book a meeting with Dr. Gabe Kalmar today!

Dr. Gabe Kalmar
Genome BC Vice President, Sector Development

GabeKalmar Genome BC

Before his current role as VP Sector Development, Dr. Gabe Kalmar was engaged in strategic consulting activities with several early stage pharmaceutical companies which included overseeing operations, implementing technology development and providing merger and acquisition planning.

Dr. Kalmar held senior management positions with Kinetek Pharmaceuticals Inc., a privately held Vancouver-based biopharmaceutical company that was acquired by QLT, in March 2004. During this time, Dr. Kalmar established and managed multiple external collaborations with academics and clinicians in the areas of signal transduction, preclinical studies and technology access.

Dr. Kalmar obtained his undergraduate science degree from the University of British Columbia and his PhD in Biology from Simon Fraser University


Dr. Rachael Ritchie
Genome BC Director, Business Development

RRitchie Genome BC

Dr. Rachael Ritchie brings to Genome BC two decades of experience in the life sciences as a researcher, manager and policy analyst. Following postdoctoral work at Harvard University (Children’s Hospital, Boston), Dr. Ritchie spent eleven years at the New Brunswick Research & productivity Council (RPC) working to identify, develop and apply technical and non-technical solutions to a range of challenges facing businesses and regional economic development in New Brunswick and Atlantic Canada.

More recently, Dr. Ritchie worked as a Policy Analyst in the OECD’s Science Technology Policy Division, working with member states and other stakeholders to develop analytical frameworks to inform science and technology policy; focal areas of her work included: innovative health governance, synthetic biology and marine biotechnology.

Dr. Ritchie holds a BSc (hons.) degree from the University of British Columbia and a DPhil in Clinical Medicine (Genetics) from the University of Oxford. Her experience spans the health, natural resource (aquaculture, fisheries, food) and biotech sectors.

Who else is available for Open Office meetings? Check out the full roster here.